Company Analysis

Twist Bioscience Corporation (TWST)

Nasdaq: TWST · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2013
Grade6.2
◀ Past 7.2● Present 7.6▶ Future 4.4
1 est.

Who runs Twist Bioscience Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Leproust Emily M.
Chief Executive Officer. First filing Oct 2018, latest Nov 5, 2026, 97 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
24 people on the record since 2018
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Leproust Emily M.Chief Executive OfficerOct 2018Nov 5, 202667 · $101M
Finn Patrick JohnPresident and COOOct 2018Nov 5, 202627 · $21.5M
Werner Robert F.Chief Accounting OfficerMay 2023Nov 5, 202619 · $1.5M
Green PaulaSVP of Human ResourcesOct 2018Nov 5, 202620 · $7.1M
Cho DennisSee RemarksSep 2021Nov 5, 202622 · $8.7M
Laponis AdamChief Financial OfficerJan 2024Oct 13, 202614 · $4.0M
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Blake KatryndirectorAug 2025Aug 14, 20261 · $300,000
Chess RobertdirectorOct 2018Aug 11, 20263 · $2.6M
Starovasnik Melissa A.directorAug 2021Jun 1, 20264 · $300,000
Johannessen JandirectorOct 2018May 14, 20263 · $1.0M
Chan Nelson CdirectorMay 2019Feb 9, 2026none
Crandell KeithdirectorOct 2018Feb 9, 2026none
Ragusa Robert PdirectorOct 2018Feb 9, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TWST · research, not advice